Home Top Movers Vapotherm, Inc. (VAPO) Stock Poised to Recover Following Reports of Promising Q1...

Vapotherm, Inc. (VAPO) Stock Poised to Recover Following Reports of Promising Q1 2021 Financials

Vapotherm, Inc. (VAPO) stock prices were down by a marginal 1.14% as of the market closing on May 5th, 2021, bringing the price per share down to USD$21.63.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Massive Increases in Revenue

The first quarter of the fiscal year 2021 reported USD32.3 million in net revenue, representing a 69% increase from the same quarter of the prior year. The company also reported total net equipment revenue that was up 123% from the quarter of the previous year, including revenue generated from products and leases.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Growth During the Pandemic

These significant increases are primarily attributable to the devastating effects of the global Covid-19 pandemic, which affects the respiratory health of infected patients, resulting in increased demand for Precision Flow units. Further contributing to the year-over-year increase, average selling prices of capital and disposables in the U.S. Total disposable revenue increased by 38%. This, in turn, was caused by the increased number of installed bases of Precision Flow units and a surge in demand for VAPO products to treat the respiratory distress in Covid-19 patients around the world.

Improved Gross Margin

Gross profit was reported to be USD$17.2 million for Q1 2021, a USD$8 million increase as compared to Q1 2020. These numbers represent a 53.1% gross margin for Q1 2021, up from 48.2% for Q1 2020. Primarily attributable to the improvement in gross margin is the substantially increases revenue and production volume for the first quarter of the fiscal year 2021 as compared to Q1 2020.

Growth Results in Higher Operating Costs

Q1 2021 saw a 5% increase in its reports of operating expenses in the amount of USD$26.9 million, as compared to the USD$21.9 million reported in the same quarter of the year prior. This increase is primarily attributable to increases in an increased workforce, auditing, and compliance costs resulting in an overall increase in general and administrative costs. Further compounding this effect, research and develop costs were also higher because of the allocation of resources towards the development of HVT 2.0, the company’s next-gen platform.

Solid Liquidity Position

The first quarter of 2021 reported a net loss of USD$10.4 million, down from the USD$13.8 million reported in the comparable quarter of the prior year. These numbers represent a net loss of USD$0.40 per common share in Q1 2021, down from USD$0.66 net loss per common share in Q1 2020. As of March 31st, 2021, VAPO reported having cash and cash equivalents amounting to USD$98.3 million.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for VAPO

With the continued devastation of the Covid-19 pandemic, VAPO finds itself facing massive increases in demand and has the solid liquidity position to leverage its resources to meet that demand. Current and potential investors are hopeful for a continued trajectory of success in the promising numbers reported for the most recent fiscal quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX...

Clover Health Investments Corp. (CLOV) stock rises during pre-market. Let’s find out why?

Clover Health Investments Corp. (NASDAQ: CLOV) stock declined by 23.61% at last close while the CLOV stock price gains by 5.73% in the pre-market...

GameStop Inc. (GME) stock plunged during after-hour session. Here’s the update

GameStop Inc. (NASDAQ: GME) stock gained by 0.85% at the last close while the GME stock price declines by 5.21% in the after-hours session....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam